ThyroMend
ThyroMend, licence 80094590: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Douglas Laboratories Canada
- NPN or DIN-HM
- 80094590
- Status
- Active licence
- Licence date
- 24 September 2019
- Revision date
- 29 March 2021
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Commiphora wightii Source : Gum oleoresin Extract : Matériel brut sec Extraction ratio : 2.0:1.0 Dry plant equivalent : 182.0 mg | 91.0 mg | Not calculated |
| Bacopa monnieri Source : Sommité Extract : Matériel brut sec Extraction ratio : 7.0:1.0 Dry plant equivalent : 539.0 mg | 77.0 mg | Not calculated |
| Withania somnifera Source : Withania somnifera - racine Extract : Matériel brut sec Extraction ratio : 1.7:1.0 Dry plant equivalent : 102.0 mg | 60.0 mg | Not calculated |
| Humulus lupulus Source : Strobiles Extract : Matériel brut sec Extraction ratio : 10.0:1.0 Dry plant equivalent : 560.0 mg | 56.0 mg | Not calculated |
| Salvia officinalis Source : Feuille | 43.0 mg | Not calculated |
| Plectranthus barbatus Source : Racine Extract : Matériel brut sec Extraction ratio : 25.0:1.0 Dry plant equivalent : 1200.0 mg | 48.0 mg | Not calculated |
| Rosmarinus officinalis Source : Feuille Potency : 0.0 8-12:1 | 42.0 mg | Not calculated |
| Ascophyllum nodosum Source : Thallus Potency : 135.0 mcg Iodine | 225.0 mg | Not calculated |
| Fucus vesiculosus Source : En entier | 8.0 mg | Not calculated |
Non-medicinal ingredients
Phosphate de dicalcium dihydraté, Hypromellose, Stéarate de magnésium, Silice
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 2.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of/Provides antioxidants. Source of antioxidants/Provides antioxidants that help fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Helps in the function of the thyroid gland. Helps to prevent iodine deficiency.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80094590
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.